Package 70010-030-01

Brand: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate

Generic: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 70010-030-01
Digits Only 7001003001
Product NDC 70010-030
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-030-01)

Marketing

Marketing Status
Marketed Since 2023-02-20
Brand dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Generic dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "40cbcbf0-8e41-789e-e063-6294a90ab711", "openfda": {"upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-030-01)", "package_ndc": "70010-030-01", "marketing_start_date": "20230220"}], "brand_name": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate", "product_id": "70010-030_40cbcbf0-8e41-789e-e063-6294a90ab711", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "70010-030", "dea_schedule": "CII", "generic_name": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate", "labeler_name": "Granules Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "2.5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "2.5 mg/1"}], "application_number": "ANDA217027", "marketing_category": "ANDA", "marketing_start_date": "20230220", "listing_expiration_date": "20261231"}